The ability of BL3.2 to block CTX activity in vivo was assessed using 5-day-old CD-1 mice, a widely used model of cholera and the recommended model for targeted (e.g., CTX) investigations35,36. Here, CYP27A1 is linked to vibrio infectious disease.